Leslie E. Martin

Angiogenic heterogeneity in head and neck squamous cell carcinoma: biological and therapeutic implications

L. Ohno-Machado, W. Kuo, M. Whipple, 2008, Laboratory Investigation.

Tissue microarray - a high-throughput molecular analysis in head and neck cancer.

Leslie E. Martin, M. Lingen, K. Satyamoorthy, 2007, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

A feed-forward loop involving protein kinase Calpha and microRNAs regulates tumor cell cycle.

J. Parker, C. Chung, Leslie E. Martin, 2009, Cancer research.

Protein kinase Cζ mediates epidermal growth factor-induced growth of head and neck tumor cells by regulating mitogen-activated protein kinase

Leslie E. Martin, M. Lingen, M. Rosner, 2006 .

Protein kinase C zeta mediates epidermal growth factor-induced growth of head and neck tumor cells by regulating mitogen-activated protein kinase.

Leslie E. Martin, M. Lingen, M. Rosner, 2006, Cancer research.

Protein kinase C Zeta mediates EGF-induced growth of head and neck tumor cells by regulating MAP kinase

Leslie E. Martin, M. Lingen, M. Rosner, 2006 .

Regulating Mitogen-Activated Protein Kinase Induced Growth of Head and Neck Tumor Cells by − Mediates Epidermal Growth Factor ζ Protein Kinase C

Leslie E. Martin, M. Lingen, M. Rosner, 2006 .

Protein Kinase C Z Mediates Epidermal Growth Factor – Induced Growth of Head and Neck Tumor Cells by Regulating Mitogen-Activated Protein Kinase

Leslie E. Martin, M. Lingen, M. Rosner, 2006 .

ABT-510 Is an Effective Chemopreventive Agent in the Mouse 4-Nitroquinoline 1-Oxide Model of Oral Carcinogenesis

R. Hasina, Leslie E. Martin, M. Lingen, 2009, Cancer Prevention Research.

Response of Some Head and Neck Cancers to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors May Be Linked to Mutation of ERBB2 rather than EGFR

Patricia L. Harris, D. Sgroi, D. Haber, 2005, Clinical Cancer Research.

The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma.

J. Christensen, R. Salgia, E. Vokes, 2009, Cancer research.